Answers - Business

Skills must be developed over a period of time, and practiced to attain an acceptable level of professional competence. Practice needs to take place within the business arena. Time has become an ever-valuable commodity

According to USFDA, a combination product is one composed of any combination of a drug and device; biological product and device; drug and biological product

and this gap between talent availability and business need resulting from high-speed business ramp-up, is one of the reasons why expatriation is an important factor in the success of the region.

There is one main ing

; or drug, device, and biological product and fixed dose combination would include two or more combinations of drug.

Examples of combination products may in

redient that is missing and that is provenance.

The difficulties associated with striving to attain superior performance in the global business arena, creates its own unique hurdles. Unfortunately, there is a line of

lude drug-coated devices, drugs packaged with delivery devices in medical kits, and drugs and devices packaged separately but intended to be used together.

thought that implies resentment towards some of the expatriate workforce from those who mistakenly believe that there is an unfair bias.

This feeling often draws attention to the connection made by hiring staff, that

here is enormous increase in the number of combination products entering the market in the recent years. Combination products have proven advantages but fixe

roles are skills and competency based and as such, this should be the leveler across all the installed talent pool. If selection of managers were solely based on these criteria and, these alone were adequate to determi

d dose combinations are still in the process of convincing regulatory authority on their advantages over the single ingredient formulations.

Combination pro

ne their fitness for purpose, then this assumption would make sense. However, it overlooks the fact that at senior level, either at functional head, specialist or business leader, quite often external requirements man

ucts have become life saving products for the pharmaceutical companies who doesn’t have many innovative molecules in their product pipeline and have been inc

date the qualifications of the new incumbent.

I believe career progression is contingent upon a combination of personal and importantly, external factors. Market drivers, competitive threat, company positioning and br

easingly used in the product life cycle management. Even the companies having product patents are trying to extend their product life cycle through the combi

and value, removal of trade barriers, regional growth and the turbulence and instability within the markets, the “whirlpool” effect, alignment with protocols such as WTO, incorrect business model causing bad hiring dec

nation products and maximize the revenues. But the companies involved in this practice are overlooking that they are burdening the patients both economically

sions, and in addition the impact of external pressure resulting in companies establishing hiring barriers and an uncertain US Dollar.

One of the main effects of WTO compliance is the removal of trade barriers enablin

and physically. They need to rightly judge the benefits of the combination products and they have to even look at the risks involved when combining the produ

g overseas companies to compete with regional based organisations, increasing consumer choice. Locally owned companies are now playing in the international business arena, large domestic companies have become internati

ts. Some of the combination products were well accepted by physicians while others suffered. Companies involved in development of combination products are fi

onal players with their home base acting as the international headquarters.

Quite often we see that new businesses are formed and are managed by for example western expats. This has raised questions within regional co

ding difficulty in defining their combination products and facing various challenges from selecting a combination to marketing it.

Following aspects would a

mmunities, for if the role has a particular scope and a particular form, then why would there be a bias.

Business is no longer regional, it is international and boundaries are dissolving and overall standards have to

dd to the challenges in developing combination products:

Which markets to tap where the combination products can do fairly well?
Which combination prod

mprove in order to become competitive, or to be the market leader, or, to simply survive.

This cannot be achieved with inexperienced staff or business inefficiency due to incorrect hiring choices. The ramp-up rates fo

cts are meaningful and rational?
Which therapeutic categories to select?
Which Combinations can address unmet needs of the patients?
Do combin

r business is rapidly increasing as the region goes though a phase of re-generation. This ramp-up is disproportionate to the availability of capable, locally available talent It is becoming increasingly more common to

tions increase the patient compliance?
What would be the developing cost?
How to tackle the risks encountered during combination product developmen

see complex strategic alliances and the establishment of innovative ventures.

In this era of collaboration, driven by for example, the need to become world class or to comply with WTO rules on monopolistic practices,

t?

As combination products don't fit into the traditional categories of drugs, medical devices, or biological products, the USFDA is in the process of devel

organisations often share intellectual platforms or they establish a combined business form to capitalize on individual business expertise. This implies the need to recruit the best available talent.

There is an incre

ping new procedures for reviewing their safety, efficacy and quality.

Professional from academic institutions, pharmaceutical industries, health care indust

sing number of major projects, with cross border assets and the need for external financing. Project finance comes from a variety of disparate sources often as a part of syndication and often amounting to several hundr

y and representatives from various regulatory agencies are working out to design the regulatory requirements for manufacture and sale of combination products

ed million US$. Investors such as western- based venture capitalists, will need to mitigate their investment risk, see a return rate in excess of 30% per annum and a workable exit strategy.

Herein lies the answer to s

.

As there is an increasing trend of the combination products companies manufacturing such products should be able to tackle the problems involved in the de

ome of the questions raised about bias. Many companies are obligated to employ key staff who are not only professionally capable, but who have the right provenance to satisfy their investors.

Regional growth and the m

elopment. They need to be wiser in analyzing the market trends and the regulatory requirements.

Companies that provide selfless information through particip

ove towards a more competitive business platform will automatically filter out those who no longer fit with tomorrows business model. This is not unfair bias and neither is it prejudicial, it is sound business necessit

tion in industry events and feedback to regulatory authorities would be able to face the challenges and will be successful in developing combination products

HTTP = HTML link (for blogs, profiles,phorums):
<a href="http://www.answers.org.ua/article/10374/answers-Provenance-the-Missing-Link-to-Success.html">Provenance, the Missing Link to Success</a>

BB link (for phorums):
[url=http://www.answers.org.ua/article/10374/answers-Provenance-the-Missing-Link-to-Success.html]Provenance, the Missing Link to Success[/url]

Have you ever noticed how companies hide behind their accounting minutia? Using various accounting rules to hide the fact they are not making money, only burning thru capital? Many a company executive will talk about how well the company is doing never will the utter a single negative comment, which might hurt their stock.

Choosing a media is like going to the grocery store. Lots of choices but not all are equal. It depends on your needs.

Positive approach to handling layoffs or redundancy. Guide to improving your chances of survival and winning through to a sound financial future. Covers what to do now and how to plan for the future.

Tags

Links

Answers - Provenance, the Missing Link to Success

Related Articles: